Clinical Trials
2 trialsNCT05057013 2025-08-11
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
Phase 1/2 Active not recruiting
NCT00740532 2010-09-02
Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients
Istituto Clinico Humanitas
Completed